Leah Wolf, MS CF-SLP | |
245 Sycamore St, Sauk City, WI 53583-1013 | |
(608) 643-3383 | |
Not Available |
Full Name | Leah Wolf |
---|---|
Gender | Female |
Speciality | Speech-language Pathologist |
Location | 245 Sycamore St, Sauk City, Wisconsin |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1750951729 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
235Z00000X | Speech-language Pathologist | 5219 (Wisconsin) | Primary |
Mailing Address | Practice Location Address |
---|---|
Leah Wolf, MS CF-SLP 245 Sycamore St, Sauk City, WI 53583-1013 Ph: () - | Leah Wolf, MS CF-SLP 245 Sycamore St, Sauk City, WI 53583-1013 Ph: (608) 643-3383 |
News Archive
The study "Effectiveness of mRNA BNT162b2 COVID-19 vaccine up to 6 months in a large integrated health system in the USA: a retrospective cohort study" is published in the journal The Lancet.
A protein which is intimately involved in cancer-promoting cell signaling also keeps a key component of the signaling pathway tied down and inactive, a team led by scientists from The University of Texas MD Anderson Cancer Center reports this week in Nature Structural Molecular Biology.
Determining the presence of cancer, as well as its type and malignancy, is a stressful process for patients that can take up to two weeks to get a diagnosis. With a new bit of technology-a sugar-transporting biosensor-researchers at Michigan Technological University hope to reduce that timeframe down to minutes.
The 12th FENS European Nutrition Conference will take place in Berlin, Germany from 20th to 23rd October 2015 and gather leading nutrition experts from around the world to discuss the latest developments in nutrition research. In conjunction with the conference, on 21st October a satellite symposium on "Regular Fat Dairy Foods in Nutrition and Health: The Latest insights" will present an update on the benefits.
Catalyst Pharmaceutical Partners, Inc. announced today that it has signed a non-binding Letter of Intent with the National Institute on Drug Abuse (NIDA) to conduct a U.S. Phase II(b) clinical trial evaluating CPP-109, Catalyst's formulation of vigabatrin, for the treatment of cocaine addiction. It is anticipated that NIDA, under their agreement with Veteran's Administration Cooperative Studies Program, will provide substantial resources for the trial and that Catalyst will contribute approximately $2.5 million in resources as part of the estimated $10 million trial cost.
› Verified 7 days ago
Jaclyn P Rhoades, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 880 Independence Ln, Sauk City, WI 53583 Phone: 608-643-2343 | |
Ms. Nicole Alfre Bauer, CF-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 880 Independence Ln, Sauk City, WI 53583 Phone: 608-644-3233 | |
Patricia J Fowler, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 880 Independence Ln, Sauk City, WI 53583 Phone: 608-643-2343 | |
Valerie Mahoney, SLP Speech-Language Pathologist Medicare: Accepting Medicare Assignments Practice Location: 880 Independence Ln, Sauk City, WI 53583 Phone: 608-643-2343 | |
Shanna L. Rufener, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 880 Independence Ln, Sauk City, WI 53583 Phone: 608-643-2343 | |
Caitlin L Ward, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 880 Independence Ln, Sauk City, WI 53583 Phone: 608-643-2343 Fax: 608-643-3801 | |
Kelly M Sherwood, SPEECH PATHOLOGIST Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 880 Independence Ln, Sauk City, WI 53583 Phone: 608-643-2343 Fax: 608-643-3801 |